(Q85306996)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107612%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Eeyarestatin causes cervical cancer cell sensitization to bortezomib treatment by augmenting ER stress and CHOP expression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107612%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

main subject

cervix uterine cancer

1 reference

German J Brem

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107612%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Ioannis Mylonas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107612%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Ansgar Brüning

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107612%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

26 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107612%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107612%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107612%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107612%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

383-390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107612%20AND%20SRC:MED&resulttype=core&format=json

Targeting the endoplasmic reticulum-stress response as an anticancer strategy

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Endoplasmic reticulum-associated degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Heat shock proteins: cell protection through protein triage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Targeting heat shock proteins 70/90 and proteasome for cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Autophagy-physiology and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Autophagy and the integrated stress response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Reticulophagy and ribophagy: regulated degradation of protein production factories.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Protein quality control in the cytosol and the endoplasmic reticulum: brothers in arms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Nelfinavir induces the unfolded protein response in ovarian cancer cells, resulting in ER vacuolization, cell cycle retardation and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Bortezomib targets the caspase-like proteasome activity in cervical cancer cells, triggering apoptosis that can be enhanced by nelfinavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Analysis of nelfinavir-induced endoplasmic reticulum stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Inhibition of p97-dependent protein degradation by Eeyarestatin I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Aggresomes: a cellular response to misfolded proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Proteasome inhibition: a promising strategy for treating cancer, but what about neurotoxicity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Dissection of the dislocation pathway for type I membrane proteins with a new small molecule inhibitor, eeyarestatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

The ERAD inhibitor Eeyarestatin I is a bifunctional compound with a membrane-binding domain and a p97/VCP inhibitory group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Eeyarestatin I inhibits Sec61-mediated protein translocation at the endoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Inhibition of protein translocation at the endoplasmic reticulum promotes activation of the unfolded protein response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Stress management at the ER: regulators of ER stress-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

The mitochondria-independent cytotoxic effect of nelfinavir on leukemia cells can be enhanced by sorafenib-mediated mcl-1 downregulation and mitochondrial membrane destabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

7 January 2021

Proteasome inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

Critical role of VCP/p97 in the pathogenesis and progression of non-small cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.10.021

10.1016/J.YGYNO.2012.10.021

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23107612%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference